BBIO · BridgeBio Pharma, Inc. · Held by Funds
You came from your AI assistant. Add Equibles to it and ask about this data directly, free.
Registered funds — mutual funds, ETFs and closed-end funds — whose latest Form N-PORT portfolio report holds this exact listed security, matched by CUSIP. Each row is one fund position with its size, value and weight in that fund.
Fund Ownership of BBIO by Fund Type
Registered funds' Form N-PORT reports for the quarter ended Jun 30, 2026Index funds and index ETFs hold 15.01% of shares outstanding.
| Fund type | Of shares outstanding | Shares |
|---|---|---|
| Index funds | 2.88% | 5,608,328 |
| Index ETFs | 12.13% | 23,621,714 |
| Active ETFs | 0.66% | 1,292,556 |
| Active funds | 16.17% | 31,504,570 |
| Unclassified | 0.54% | 1,049,626 |
| All registered funds | 32.38% | 63,076,794 |
How fund types are measured
Each fund series counts once, with its latest Form N-PORT report dated inside the quarter; only long share positions count, restated to today's split basis. The fund type is the series' latest Form N-CEN answer on or before the quarter end (the index-fund box and the exchange-traded flag), never its name. Unclassified funds have no usable N-CEN; unit investment trusts are among them, so index ownership is a floor. Funds sit inside their advisers' 13F reports, so these shares overlap the 13F figures and are never added to them.
Funds holding BBIO
479 fund positions| Fund | Ticker | Balance | Value | % of Fund | Side | Reported | Open |
|---|---|---|---|---|---|---|---|
| VANGUARD TOTAL STOCK MARKET INDEX FUND | — | 5,600,403 | $417,118,015 | 0.02% | Long | 2026-06-30 | |
| VANGUARD SMALL-CAP INDEX FUND | — | 4,039,952 | $300,895,625 | 0.16% | Long | 2026-06-30 | |
| VANGUARD HEALTH CARE FUND | — | 3,162,851 | $253,312,737 | 0.66% | Long | 2026-07-31 | |
| VANGUARD SMALL-CAP GROWTH INDEX FUND | — | 2,330,329 | $173,562,904 | 0.37% | Long | 2026-06-30 | |
| VANGUARD EXTENDED MARKET INDEX FUND | — | 1,974,544 | $147,064,037 | 0.15% | Long | 2026-06-30 | |
| Janus Henderson Enterprise Fund | — | 1,909,659 | $142,231,402 | 0.64% | Long | 2026-06-30 | |
| VANGUARD EXPLORER FUND | — | 1,724,983 | $138,153,888 | 0.62% | Long | 2026-07-31 | |
| Janus Henderson Global Life Sciences Fund | — | 1,590,382 | $118,451,651 | 2.04% | Long | 2026-06-30 | |
| State Street(R) SPDR(R) S&P(R) Biotech ETF | XBI | 1,477,181 | $110,020,441 | 1.02% | Long | 2026-06-30 | |
| Invesco Discovery Fund | — | 1,378,526 | $105,581,306 | 1.42% | Long | 2026-08-31 | |
| iShares Biotechnology ETF | IBB | 1,198,062 | $89,231,658 | 0.98% | Long | 2026-06-30 | |
| JPMorgan Mid Cap Growth Fund | — | 1,150,147 | $85,662,949 | 0.65% | Long | 2026-06-30 | |
| iShares Russell Mid-Cap Growth ETF | IWP | 940,494 | $70,047,993 | 0.32% | Long | 2026-06-30 | |
| Select Biotechnology Portfolio | FBIOX | 895,543 | $68,589,638 | 1.09% | Long | 2026-08-31 | |
| Fidelity Extended Market Index Fund | FSMAX | 839,545 | $64,300,752 | 0.16% | Long | 2026-08-31 | |
| Schwab U.S. Small-Cap ETF | SCHA | 819,761 | $62,785,495 | 0.28% | Long | 2026-08-31 | |
| Janus Henderson Triton Fund | — | 814,465 | $60,661,353 | 1.02% | Long | 2026-06-30 | |
| Lord Abbett Growth Leaders Fund | — | 661,977 | $53,017,738 | 0.71% | Long | 2026-07-31 | |
| Franklin Dynatech Fund | — | 700,000 | $52,136,000 | 0.17% | Long | 2026-06-30 | |
| iShares Russell Mid-Cap ETF | IWR | 694,222 | $51,705,655 | 0.09% | Long | 2026-06-30 | |
| Fidelity Mid Cap Index Fund | FSMDX | 640,536 | $51,300,528 | 0.10% | Long | 2026-07-31 | |
| Hood River Small-Cap Growth Fund | — | 684,355 | $50,970,760 | 0.77% | Long | 2026-06-30 | |
| SMALLCAP World Fund Inc | — | 681,290 | $50,742,479 | 0.05% | Long | 2026-06-30 | |
| Janus Henderson Venture Fund | — | 637,802 | $47,503,493 | 1.31% | Long | 2026-06-30 | |
| Nomura Small Cap Core Fund | — | 619,588 | $47,454,245 | 0.91% | Long | 2026-08-31 | |
| iShares Russell 1000 Growth ETF | IWF | 609,911 | $45,426,171 | 0.04% | Long | 2026-06-30 | |
| HARTFORD CORE EQUITY FUND | — | 550,591 | $44,096,833 | 0.39% | Long | 2026-07-31 | |
| Schwab U.S. Mid-Cap ETF | SCHM | 476,763 | $36,515,278 | 0.25% | Long | 2026-08-31 | |
| Columbia Small Cap Growth Fund | — | 473,939 | $36,298,988 | 1.03% | Long | 2026-08-31 | |
| PRIMECAP Odyssey Aggressive Growth Fund | POAGX | 448,600 | $35,928,374 | 0.49% | Long | 2026-07-31 | |
| Small Cap Growth Fund | — | 433,657 | $34,731,589 | 0.62% | Long | 2026-07-31 | |
| VANGUARD HEALTH CARE INDEX FUND | — | 448,408 | $34,343,569 | 0.16% | Long | 2026-08-31 | |
| Franklin Small Cap Growth Fund | — | 424,752 | $34,018,388 | 1.38% | Long | 2026-07-31 | |
| Eventide Healthcare & Life Sciences Fund | — | 437,130 | $32,557,442 | 1.82% | Long | 2026-06-30 | |
| AB DISCOVERY GROWTH FUND, INC. | — | 433,700 | $32,301,976 | 1.11% | Long | 2026-06-30 | |
| Janus Henderson Global Select Fund | — | 417,291 | $31,079,834 | 0.95% | Long | 2026-06-30 | |
| VANGUARD CAPITAL OPPORTUNITY FUND | — | 406,400 | $30,268,672 | 0.09% | Long | 2026-06-30 | |
| Fidelity Small Cap Growth Fund | — | 369,159 | $29,565,944 | 0.34% | Long | 2026-07-31 | |
| Janus Henderson Research Fund | — | 390,963 | $29,118,924 | 0.10% | Long | 2026-06-30 | |
| Columbia Acorn Fund | — | 389,814 | $29,033,347 | 1.05% | Long | 2026-06-30 | |
| LORD ABBETT DEVELOPING GROWTH FUND INC | — | 356,111 | $28,520,930 | 1.28% | Long | 2026-07-31 | |
| Invesco Discovery Mid Cap Growth Fund | — | 342,286 | $27,413,686 | 0.40% | Long | 2026-07-31 | |
| SmallCap Fund | — | 338,500 | $27,110,465 | 1.30% | Long | 2026-07-31 | |
| T. Rowe Price Health Sciences Fund, Inc. | — | 363,249 | $27,054,786 | 0.23% | Long | 2026-06-30 | |
| Fidelity Total Market Index Fund | FSKAX | 328,390 | $25,151,390 | 0.02% | Long | 2026-08-31 | |
| Federated Hermes MDT Mid Cap Growth Fund | — | 309,426 | $24,781,928 | 0.38% | Long | 2026-07-31 | |
| JNL/JPMorgan MidCap Growth Fund | — | 311,523 | $23,202,233 | 0.65% | Long | 2026-06-30 | |
| Neuberger Mid Cap Growth Fund | — | 292,573 | $22,408,166 | 1.04% | Long | 2026-08-31 | |
| Allspring Growth Fund | — | 276,834 | $22,171,635 | 0.77% | Long | 2026-07-31 | |
| Strategic Advisers U.S. Total Stock Fund | FSAKX | 287,656 | $22,031,573 | 0.02% | Long | 2026-08-31 |